Elanco Animal Health (ELAN) Free Cash Flow (2017 - 2026)

Elanco Animal Health has disclosed Free Cash Flow across 10 years of filings, most recently posting $244.0 million for Q2 2026.

• In Q2 2026, Free Cash Flow rose 35.56% year-over-year to $244.0 million; the TTM figure through Jun 2026 stood at $379.0 million (up 4.99% YoY), while the FY2025 annual figure was $284.0 million, down 27.92% from the prior year.
• Free Cash Flow came in at $244.0 million for Q2 2026 at Elanco Animal Health, up from -$38.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $273.0 million in Q2 2022 to a low of -$169.0 million in Q1 2023.
• Average Free Cash Flow over 5 years is $72.0 million, with a median of $118.0 million recorded in 2023.
• Year-over-year, Free Cash Flow plunged 2125.0% in 2022 and surged 773.68% in 2024.
• Over 5 years, Free Cash Flow stood at -$64.0 million in 2022, then surged by 281.25% to $116.0 million in 2023, then rose by 12.07% to $130.0 million in 2024, then slumped by 64.62% to $46.0 million in 2025, then surged by 430.43% to $244.0 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $244.0 million in Q2 2026, -$38.0 million in Q1 2026, and $46.0 million in Q4 2025.